XML 23 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 03, 2017
Jan. 29, 2016
Jan. 30, 2015
Statement of Cash Flows [Abstract]      
Net loss $ (38,213) $ (72,381) $ (38,490)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 39,425 40,638 41,425
Change in fair value of convertible notes 132 5,493 0
Stock-based compensation expense 8,883 841 785
Effects of exchange rate changes on monetary assets and liabilities denominated in foreign currencies (2,239) 836 137
Income tax expense (benefit) (25,264) (40,196) (22,745)
Other non cash impacts 0 4,792 7,202
Excess tax benefit from share-based payment (221) 0 0
Provision for doubtful accounts 2,613 4,661 768
Changes in assets and liabilities:      
Accounts receivable 956 (52,443) (24,527)
Due to / from parent (15,582) 21,691 0
Inventories 1,610 (1,179) (1,389)
Other assets (139) (10,065) (3,856)
Accounts payable 2,041 2,311 5,570
Deferred revenue 7,185 34,591 34,275
Accrued and other liabilities 11,975 50,567 3,077
Net cash provided by (used in) operating activities (6,838) (9,843) 2,232
Cash flows from investing activities:      
Capital expenditures (19,361) (9,023) (9,542)
Net cash used in investing activities (19,361) (9,023) (9,542)
Cash flows from financing activities:      
Proceeds from initial public offering, net 99,604 0 0
Capital contribution from parent, net 9,547 0 0
Excess tax benefit from share-based payment 221 0 0
Transfers from parent, net 0 24,383 11,553
Payment of deferred offering costs 0 (1,264) 0
Issuance of convertible notes 0 22,500 0
Net cash provided by financing activities 109,372 45,619 11,553
Net increase in cash and cash equivalents 83,173 26,753 4,243
Cash and cash equivalents at beginning of the period 33,422 6,669 2,426
Cash and cash equivalents at end of the period 116,595 33,422 6,669
Supplemental Disclosures of Non-Cash Investing and Financing Activities:      
Conversion of convertible notes to common stock 28,125 0 0
Financed capital expenditures 800 0 0
Income taxes paid $ 910 $ 0 $ 0